These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 32543142)
41. Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma. Emruli VK; Olsson R; Ek F; Ek S BMC Cancer; 2016 Jul; 16():493. PubMed ID: 27430213 [TBL] [Abstract][Full Text] [Related]
42. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Dictor M; Ek S; Sundberg M; Warenholt J; György C; Sernbo S; Gustavsson E; Abu-Alsoud W; Wadström T; Borrebaeck C Haematologica; 2009 Nov; 94(11):1563-8. PubMed ID: 19880779 [TBL] [Abstract][Full Text] [Related]
43. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression. Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940 [TBL] [Abstract][Full Text] [Related]
44. Diagnostic accuracy of SOX11 immunohistochemistry in mantle cell lymphoma: A meta-analysis. Lee W; Shin E; Kim BH; Kim H PLoS One; 2019; 14(11):e0225096. PubMed ID: 31714947 [TBL] [Abstract][Full Text] [Related]
45. SOX11 is a mantle cell lymphoma oncogene. Ferrando AA Blood; 2013 Mar; 121(12):2169-70. PubMed ID: 23520328 [No Abstract] [Full Text] [Related]
48. The role of SOX11 in mantle cell lymphoma. Lu TX; Li JY; Xu W Leuk Res; 2013 Nov; 37(11):1412-9. PubMed ID: 24001358 [TBL] [Abstract][Full Text] [Related]
49. Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma. Sureda-Gómez M; Balsas P; Rodríguez ML; Nadeu F; De Bolòs A; Eguileor Á; Kulis M; Castellano G; López C; Giné E; Demajo S; Jares P; Martín-Subero JI; Beà S; Campo E; Amador V Leukemia; 2023 Feb; 37(2):408-421. PubMed ID: 36509891 [TBL] [Abstract][Full Text] [Related]
50. SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma. Palomero J; Vegliante MC; Rodríguez ML; Eguileor A; Castellano G; Planas-Rigol E; Jares P; Ribera-Cortada I; Cid MC; Campo E; Amador V Blood; 2014 Oct; 124(14):2235-47. PubMed ID: 25092176 [TBL] [Abstract][Full Text] [Related]
51. SOXC and MiR17-92 gene expression profiling defines two subgroups with different clinical outcome in mantle cell lymphoma. Roisman A; Huamán Garaicoa F; Metrebian F; Narbaitz M; Kohan D; García Rivello H; Fernandez I; Pavlovsky A; Pavlovsky M; Hernández L; Slavutsky I Genes Chromosomes Cancer; 2016 Jun; 55(6):531-40. PubMed ID: 26998831 [TBL] [Abstract][Full Text] [Related]
52. SOX11 expression as a MRD molecular marker for MCL in comparison with t(11;14) and IGH rearrangement. Szostakowska M; Szymczyk M; Badowska K; Tudek B; Fabisiewicz A Med Oncol; 2018 Mar; 35(4):49. PubMed ID: 29520657 [TBL] [Abstract][Full Text] [Related]
53. CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. Salaverria I; Royo C; Carvajal-Cuenca A; Clot G; Navarro A; Valera A; Song JY; Woroniecka R; Rymkiewicz G; Klapper W; Hartmann EM; Sujobert P; Wlodarska I; Ferry JA; Gaulard P; Ott G; Rosenwald A; Lopez-Guillermo A; Quintanilla-Martinez L; Harris NL; Jaffe ES; Siebert R; Campo E; Beà S Blood; 2013 Feb; 121(8):1394-402. PubMed ID: 23255553 [TBL] [Abstract][Full Text] [Related]
54. Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Nygren L; Baumgartner Wennerholm S; Klimkowska M; Christensson B; Kimby E; Sander B Blood; 2012 May; 119(18):4215-23. PubMed ID: 22431568 [TBL] [Abstract][Full Text] [Related]
55. Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients. Righi S; Pileri S; Agostinelli C; Bacci F; Spagnolo S; Sabattini E Hum Pathol; 2017 Jan; 59():94-101. PubMed ID: 27720733 [TBL] [Abstract][Full Text] [Related]
56. SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma. Kuci V; Nordström L; Conrotto P; Ek S Leuk Lymphoma; 2016 Aug; 57(8):1883-92. PubMed ID: 26757780 [TBL] [Abstract][Full Text] [Related]
57. SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma. Jatiani SS; Christie S; Leshchenko VV; Jain R; Kapoor A; Bisignano P; Lee C; Kaniskan HÜ; Edwards D; Meng F; Laganà A; Youssef Y; Wiestner A; Alinari L; Jin J; Filizola M; Aggarwal AK; Parekh S Clin Cancer Res; 2021 Aug; 27(16):4652-4663. PubMed ID: 34158358 [TBL] [Abstract][Full Text] [Related]
58. Utility and diagnostic pitfalls of SOX11 monoclonal antibodies in mantle cell lymphoma and other lymphoproliferative disorders. Nakashima MO; Durkin L; Bodo J; Lin J; Quintanilla-Martinez L; Fu K; Hsi ED Appl Immunohistochem Mol Morphol; 2014; 22(10):720-7. PubMed ID: 25229384 [TBL] [Abstract][Full Text] [Related]
59. SOX11 inhibits tumor proliferation and promotes cell adhesion mediated-drug resistance via a CD43 dependent manner in mantle cell lymphoma. Yang R; Huo Z; Duan Y; Tong W; Zheng Y; Su Y; Lou L; Zhang Q; Xu S; Peng C; Kuang D; Wang G Leuk Lymphoma; 2020 Sep; 61(9):2068-2081. PubMed ID: 32449421 [TBL] [Abstract][Full Text] [Related]
60. Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma. Beà S; Amador V Curr Oncol Rep; 2017 Jun; 19(6):43. PubMed ID: 28466437 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]